New Jersey S884 prohibits state pension and annuity funds from investing in Chinese pharmaceutical companies.
New Jersey S884 prohibits the state from investing pension and annuity funds in Chinese pharmaceutical companies. The bill defines a "Chinese pharmaceutical company" as any company with its principal place of business in China, at least 51 percent owned and controlled by a Chinese citizen, a civilian-run enterprise, or the Chinese state government. The State Investment Council, in consultation with an independent research firm, must take action to divest from any such companies. The Division of Investment must report annually on the progress of divestiture.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.